Human metapneumovirus: Review of an important respiratory pathogen

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages 45-52

  Panda, Swagatika ^a   Mohakud, Nirmal Kumar ^a   Pena, Lindomar ^b   Kumar, Subrat ^a  

^a KIIT UNIVERSITY   (India)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Bronchiolitis; Human metapneumovirus; Respiratory diseases; Viral pneumonia

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; LIVE VACCINE; MONOCLONAL ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; SMALL INTERFERING RNA; SUBUNIT VACCINE; VIRUS VACCINE;

BRONCHIOLITIS; CELL CULTURE; CELL LINE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; HOSPITALIZATION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PNEUMOVIRINAE; PNEUMOVIRUS INFECTION; REINFECTION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIROGENESIS; VIRUS DETECTION; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PHYSIOLOGY; RESPIRATORY TRACT INFECTIONS; VIROLOGY;

HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 84901828438     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.03.1394     Document Type: Review

References (102)

1. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., Dye C. Estimates of worldwide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002, 2:25-32.
2. Shapiro E. Epidemiology of acute respiratory infections. Semin Pediatr Infect Dis 1998, 9:31-36.
3. Broor S., Bharaj P., Chahar H.S. Human metapneumovirus: a new respiratory pathogen. J Biosci 2008, 33:483-493.
4. Weigl J.A., Puppe W., Grondahl B., Schmitt H.J. Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse transcriptase polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2000, 19:336-343.
5. Van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001, 7:719-724.
6. Turner P., Turner C., Watthanaworawit W., Carrara V., Cicelia N., Deglise C., et al. Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border. BMC Infect Dis 2013, 13:434.
7. Lu G., Li J., Xie Z., Liu C., Guo L., Vernet G., et al. Human metapneumovirus associated with community-acquired pneumonia in children in Beijing, China. J Med Virol 2013, 85:138-143.
8. López-Huertas M.R., Casas I., Acosta-Herrera B., García M.L., Coiras M.T., Pérez-Breña P. Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates. J Virol Methods 2005, 129:1-7.
9. Maggi F., Pifferi M., Vatteroni M., Fornai C., Tempestini E., Anzilotti S., et al. Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol 2003, 41:2987-2991.
10. Williams J.V., Harris P.A., Tollefson S.J., Halburnt R.L., Pingsterhaus J.M., Edwards K.M., et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004, 350:443-450.
11. van den Hoogen B.G., Herfst S., Sprong L., Cane P.A., Forleo-Neto E., de Swart R.L., et al. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 2004, 10:658-666.
12. Boivin G., Mackay I., Sllots T.P., Madhi S., Freymuth F., Wolf D., et al. Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis 2004, 10:1154-1157.
13. Lo M.S., Brazas R.M., Holtzman M.J. Respiratory syncytial virus non-structural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 2005, 79:9315-9319.
14. Ditt V., Lusebrink J., Tillmann R.L., Schildgen V., Schildgen O. Respiratory infections by HMPV and RSV are clinically indistinguishable but induce different host response in aged individuals. PLoS One 2011, 6:e16314.
15. Biacchesi S., Murphy B.R., Collins P.L., Buchholz U.J. Frequent frame shift and point mutation in the SH gene of human metapneumovirus passaged in vitro. J Virol 2007, 81:6057-6067.
16. Feuillet F., Lina B., Rosa-Calatrava M., Boivin G. Ten years of human metapneumovirus research. J Clin Virol 2012, 53:97-105.
17. Chang A., Masante C., Buchholz U.J., Dutch R.E. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol 2012, 86:3230-3243.
18. Schickli J.H., Kaur J., MacPhail M., Guzzetta J.M., Spaete R.R., Tang R.S. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters. Virol J 2008, 5:69.
19. Ren J., Wang Q., Kolli D., Prusak D.J., Tseng C.T., Chen Z.J., et al. Human metapneumovirus M2-2 protein inhibits innate cellular signalling by targeting MAVS. J Virol 2012, 86:13049-13061.
20. Kolli D., Bao X., Casola A. Human metapneumovirus antagonism of innate immune responses. Viruses 2012, 4:3551-3571.
21. Cespedes P.F., Gonzalez P.A., Kalergis A.M. Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells. Immunology 2013, 139:366-376.
22. Piyaratna R., Tollefson S.J., Williams J.V. Genomic analysis of four human metapneumovirus prototypes. Virus Res 2011, 160:200-205.
23. Pilger D.A., Cantarelli V.V., Amentea S.L., Leistner-Segal S. Detection of human bocavirus and human metapneumovirus by real-time PCR from patients with respiratory symptoms in Southern Brazil. Mem Inst Oswaldo Cruz 2011, 106:56-60.
24. Choi E.H., Lee H.J., Kim S.J., Eun B.W., Kim N.H., Lee J.A., et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect disease 2006, 43(5):585-592.
25. Mizuta K., Abiko C., Akoi Y., Ikeda T., Matsuza Y., Itagaki T., et al. Seasonal patterns of respiratory syncytial virus, influenza A virus, human metapneumovirus and parainfluenza virus type 3 on the basis of virus isolation data between 2004 and 2011 in Yamagata, Japan. Jpn J Infect Dis 2013, 66:140-145.
26. Chan P.C., Wang C.Y., Wu P.S., Chang P.Y., Yang T.T., Chiang Y.P., et al. Detection of human metapneumovirus in hospitalized children with acute respiratory tract infection using real-time RT-PCR in a hospital in northern Taiwan. J Formos Med Assoc 2007, 106:16-24.
27. Kahn J.S. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006, 19:546-557.
28. Hamelin M.E., Cote S., Laforge J., Lampron N., Bourbeau J., Weiss K., et al. Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 2005, 41:498-502.
29. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Cote S., et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002, 186:1330-1334.
30. Falsey A.R., Erdman D., Anderson L.J., Walsh E.E. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003, 187:785-790.
31. Williams J.V., Martino R., Rabella N., Otegui M., Parody R., Heck J.M., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 2005, 192:1061-1065.
32. Dokos C., Masjosthusmann K., Rellensmann G., Werner C., Schuler L.S., Muller K.M., et al. Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2013, 15:97-101.
33. Duchamp M.B., Lina B., Trompette A., Moret H., Motte J., Andreoletti L. Detection of human metapneumovirus RNA sequences in nasopharyngeal aspirates of young French children with acute bronchiolitis by real-time reverse transcriptase PCR and phylogenetic analysis. J Clin Microbiol 2005, 43:1411-1414.
34. Pelletier G., Dery P., Abed Y., Boivin G. Respiratory tract re-infections by the new human metapneumovirus in an immunocompromised child. Emerg Infect Dis 2002, 8:976-978.
35. Principi N., Esposito S. Paediatric human metapneumovirus infection: epidemiology, prevention and therapy. J Clin Virol 2014, 59:141-147.
36. Vicente D., Montes M., Cilla G., Perez-Yarza E.G., Perez-Trallero E. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin Infect Dis 2006, 42:111-113.
37. Papenburg J., Carbonneau J., Isabel S., Bergeron M.G., Williams J.V., De Serres G., et al. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade. J Clin Virol 2013, 58:541-547.
38. Edwards K.M., Zhu Y., Griffin M.R., Weinberg G.A., Hall C.B., Szilagyi P.G., et al. New vaccine surveillance network burden of human metapneumovirus infection in young children. N Engl J Med 2013, 368:633-643.
39. Kim S., Sung H., Im H.J., Hong S.J., Kim M.N. Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus infection in a pediatric hemato-oncology patient population. J Clin Microbiol 2009, 47:1221-1224.
40. Tu C.C., Chen L.K., Lee Y.S., Ko C.F., Chen C.M., Yang H.H., et al. An outbreak of human metapneumovirus infection in hospitalized psychiatric adult patients in Taiwan. Scand J Infect Dis 2009, 41:363-367.
41. Outbreaks of human metapneumovirus in two skilled nursing facilities-West Virginia and Idaho, 2011-2012. MMWR Morb Mortal Wkly Rep 2013, 62:909-913. Centers for Disease Control and Prevention (CDC).
42. Greensill J., McNamara P.S., Dove W., Flanagan B., Smyth R.L., Hart C.A. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003, 9:372-375.
43. Fathima S., Lee B.E., May-Hadford J., Mukhi S., Drews S.J. Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012). Viruses 2012, 4:2754-2765.
44. Esposito S., Daleno C., Prunotto G., Scalla A., et al. Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses. Influenza Other Respir Viruses 2013, 7:18-26.
45. Lin T.Y., Huang Y.C., Tsao K.C., Huang Y.L. Human metapneumovirus and community-acquired pneumonia in children. Chang Gung Med J 2005, 28:683-688.
46. Ghattas C., Mossad S.B. Fatal human metapneumovirus and influenza B virus coinfection in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis 2012, 14:e41-e43.
47. Leung J., Esper F., Weibel C., Kahn J.S. Sero-epidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 2005, 43:1213-1219.
48. Choi E.H., Lee H.J., Kim S.J., Eun B.W., Kim N.H., Lee J.A., et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis 2006, 43:585-592.
49. Semple M.G., Cowell A., Dove W., Greensill J., McNamara P.S., Halfhide C., et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 2005, 191:382-386.
50. Foulongne V., Guyon G., Rodière M., Segondy M. Human metapneumovirus infection in young children hospitalized with respiratory tract disease. Pediatr Infect Dis J 2006, 25:354-359.
51. Van Woensel J.B., Bos A.P., Lutter R., Rossen J.W., Schuurman R. Absence of human metapneumovirus co-infection in cases of severe respiratory syncytial virus infection. Pediatr Pulmonol 2006, 41:872-874.
52. Lazar I., Weibel C., Dziura J., Ferguson D., Landry M.L., Kahn J.S. Human metapneumovirus and severity of respiratory syncytial virus disease. Emerg Infect Dis 2004, 10:1318-1320.
53. Boivin G., De Serres G., Cote S., Gilca R., Abed Y., Rochette L., et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003, 9:634-640.
54. Matsuda S., Nakamura M., Hirano E., Kiyota N., Omura T., Suzuki Y., et al. Characteristics of human metapneumovirus infection prevailing in hospital wards housing patients with severe disabilities. Jpn J Infect Dis 2013, 66:195-200.
55. Van den Hoogen B.G., van Doornum G.J., Fockens J.C., Cornelissen J.J., Beyer W.E., de Groot R., et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003, 188:1571-1577.
56. Williams J.V., Tollefson S.J., Nair S., Chonmaitree T. Association of human metapneumovirus with acute otitis media. Int J Pediatr Otorhinolaryngol 2006, 70:1189-1193.
57. Jartti T., van den Hoogen B.G., Garofalo R.P., Osterhaus A.P., Ruuskanen O. Metapneumovirus and acute wheezing in children. Lancet 2002, 360:1393-1394.
58. Williams J.V., Crowe J.E., Enriquez R., Minton P., Peebles R.S., Hamilton R.G., et al. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect 2005, 192:1149-1153.
59. Perotin J.M., Dury S., Renois F., Deslee G., Wolak A., Duval V., et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol 2013, 85:866-873.
60. Ilvan A., Aslan G., Serin M.S., Calikoglu M., Yilmaz F.M., Tezcan S., et al. Investigation of the presence of human metapneumovirus in patients with chronic obstructive pulmonary disease and asthma and its relationship with the attacks. Mikrobiyol Bul 2013, 47:636-649.
61. Jain B., Singh A.K., Dangi T., Agarwal A., Verma A.K., Dwivedi M., et al. High prevalence of human metapneumovirus subtype B in cases presenting as severe acute respiratory illness: an experience at tertiary care hospital. Clin Respir J 2014, 8(2):225-233.
62. Arnold J.C., Singh K.K., Milder E., Spector S.A., Sawyer M.H., Gavali S., et al. Human metapneumovirus associated with central nervous system infection in children. Pediatr Infect Dis J 2009, 28:1057-1060.
63. Bosis S., Esposito S., Osterhaus A.D., Tremolati E., Begliatti E., Tagliabue C., et al. Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection. J Clin Virol 2008, 42:286-290.
64. Peng D., Zhao X., Liu E., Huang Y., Yang X., Zhao Y., et al. Analysis of viral load in children infected with human metapneumovirus. Iran J Pediatr 2010, 20:393-400.
65. Talaat K.R., Karron R.A., Thumar B., MacMohan B.A., Schmidt A.C., Collins P.L., Buchholz U.J. Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis. 2013, 208(10):1669-1678.
66. Englund J.A., Boeckh M., Kuypers J., Nichols W.G., Hackman R.C., Morrow R.A., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006, 144:344-349.
67. Sumino K.C., Agapov E., Pierce R.A., Trulock E.P., Pfeifer J.D., Ritter J.H., et al. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis 2005, 192:1052-1060.
68. Hopkins M.J., Redmond C., Shaw J.M., Hart I.J., Hart C.A., Smyth R.L., et al. Detection and characterisation of human metapneumovirus from children with acute respiratory symptoms in north-west England. UK. J Clin Virol 2008, 42:273-279.
69. Wei Y.H., Tsao K.C., Huang C.G., Huang Y.C., Lin T.Y. Clinical feature of different genotypes/genogroups of human metapneumovirus in hospitalized children. J Microbiol Immunol Infection 2013, 46:352-357.
70. Alvarez R., Tripp R.A. The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J Virol 2005, 79:5971-5978.
71. Laham F.R., Israele V., Casellas J.M., Garcia A.M., Lac Prugent C.M., Hoffman S.J., et al. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 2004, 189:2047-2056.
72. Lara M., Ghosh A., Plata A. Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 2012, 87:1242-1251.
73. Ren J., Kolli D., Deng J., Fang R., Gong B., Xue M., et al. MyD88 controls human metapneumovirus-induced pulmonary immune responses and disease pathogenesis. Virus Res 2013, 176:241-250.
74. Schildgen O., Glatzel T., Geikowski T., Scheibner B., Matz B., Bindl L., et al. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis 2005, 11:467-470.
75. Tollefson S.J., Cox R.G., Williams J.V. Studies of culture conditions and environmental stability of human metapneumovirus. Virus Res 2010, 151:54-59.
76. Schildgen V., Lusebrink J., Ditt V., Tillmann R., Simon A., Muller A., et al. Human HepG2 cells support respiratory syncytial virus and human metapneumovirus replication. J Virol Methods 2010, 163:74-81.
77. Isaeva E.I., Kozulina I.S., Podcherniaeva R.I., Grinkevich O.M. Reproduction of the metapneumovirus in different cell lines. Vopr Virusol 2012, 57:19-23.
78. Matsuzaki Y., Mizuta K., Takashita E., Okamoto M., Itagaki T., Katsushima F., et al. Comparison of virus isolation using the Vero E6 cell line with rt RT-PCR assay for detection of hMPV. BMC Infect Dis 2010, 10:170.
79. Pujol B.S., Vabret A., Legrand L., Dina J., Gouarin S., Lecherbonnier J.P., et al. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods 2005, 126:53-63.
80. Litwin C.M., Bosley J.G. Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical centre. Arch Virol 2014, 159(1):65-72.
81. Bharaj P., Sullender W.M., Kabra S.K., Mani K., Cherian J., Tyagi V., et al. Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. Virol J 2009, 6:89.
82. Choudhury M.L., Anand S.P., Heydari M., Rane G., Potdar V.A., Chandha M.S., et al. Development of a multiplex one step RT PCR that detects eighteen respiratory viruses in clinical specimens in comparison with real time RT-PCR. J Virol Methods 2013, 189:15-19.
83. Jokela P., Piiparinen H., Luiro K., Lappalainen M. Detection of hMPV and RSV by duplex real time PCR assay in comparison with DFA. Clin Microbiol Infect 2012, 16:1568-1573.
84. Wyde P.R., Chetty S.N., Jewell A.M., Boivin G., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003, 60:51-59.
85. Kitanovski L., Kopriva S., Pokorn M., Dolnicar M.B., Rajic V., Stefanovic M., et al. Treatment of severe human metapneumovirus pneumonia in an immunocompromised child with oral ribavirin and IVIG. J Pediatr Hematol Oncol 2013, 35:e311-e313.
86. Hamelin M.E., Gagnon C., Prince G.A., Kiener P., Suzich J., Ulbrandt N., et al. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antiviral Res 2010, 88:31-37.
87. Ulbrandt N.D., Ji H., Patel N.K., Riggs J.M., Brewah Y.A., Ready S., et al. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J Virol 2006, 80:7799-7806.
88. Corti D., Bianchi S., Vanzetta F., Minola A., Perez L., Agatic G., et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 2013, 501:439-443.
89. Deffrasness C., Hamelin M.E., Prince G.A., Boivin G. Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob Agents Chemother 2008, 52:279-287.
90. Deffrasnes C., Cavanagh M.H., Goyette N., Cui K., Ge Q., Seth S., et al. Inhibition of human metapneumovirus replication by small interfering RNA. Antivir Ther 2008, 13:821-832.
91. Darniot M., Schildgen V., Schildgen O., Sproat B., Kleines M., Ditt V., et al. RNA interference in vitro and in vivo using Dsi RNA targeting the nucleocapsid N mRNA of human metapneumovirus. Antiviral Res 2012, 93:364-373.
92. Hamelin M.E., Couture C., Sackett M.K., Boivin G. Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J Gen Virol 2007, 88:3391-3400.
93. Herd K.A., Mahalingam S., Mackay I.M., Nissen M., Sloots T.P., Tindle R.W. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol 2006, 80:2034-2044.
94. Tang R.S., Schickli J.H., MacPhail M., Fernandes F., Bicha L., Spaete J., et al. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol 2003, 77:10819-10828.
95. Skiadopolous M.H., Biacchesi S., Buchholz U.J., Amaro-Carambot E., Surman S.R., Collins P.L., et al. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 2006, 345:492-501.
96. Cseke G., Wright D.W., Tollefson S.J., Johnson J.E., Crowe J.E., Williams J.V. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 2007, 81:698-707.
97. Herfst S., de Graaf M., Schrauwen E.J., Ulbrandt N.D., Barnes A.S., Senthil K., et al. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J Gen Virol 2007, 88:2702-2709.
98. Herfst S., Schrauwen E.J., de Graaf M., van Amerongen G., van den Hoogen B.G., de Swart R.L., et al. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine 2008, 26:4224-4230.
99. Levy C., Aerts L., Hamelin M.E., Granier C., Szecsi J., Lavillette D., et al. Virus like particle vaccine induces cross protection against human metapneumovirus infection in mice. Vaccine 2013, 31:2778-2785.
100. Smith K. The use of plasmid-based reverse genetics to generate influenza virus strains for improved vaccine production. MMG 445 Basic Biotechnology eJournal 2007, 3:123-130.
101. Biacchesi S., Pham Q.N., Skiadopoulos M.H., Murphy B.R., Collins P.L., Buchholz U.J. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 2005, 79:12608-12613.
102. Liu P., Shu Z., Qin X., Dou Y., Zhao Y., Zhao X. A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c Mice. Clin Vaccine Immunol 2013, 20:1246-1254.